Formyl Peptide Receptors and Annexin A1: Complementary Mechanisms to Infliximab in Murine Experimental Colitis and Crohn’s Disease

Non-responsiveness to anti-TNF-α therapies presents relevant rates in inflammatory bowel disease patients, presenting the need to find biomarkers involved in therapeutic efficacy. Herein, we demonstrate that higher levels of colonic formyl peptide receptor 1 and annexin A1 correlate with histologica...

Descripción completa

Detalles Bibliográficos
Autores principales: de Paula-Silva, Marina, da Rocha, Gustavo Henrique Oliveira, Broering, Milena Fronza, Queiroz, Maria Luíza, Sandri, Silvana, Loiola, Rodrigo Azevedo, Oliani, Sonia Maria, Vieira, Andrea, Perretti, Mauro, Farsky, Sandra Helena Poliselli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484756/
https://www.ncbi.nlm.nih.gov/pubmed/34603288
http://dx.doi.org/10.3389/fimmu.2021.714138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484756/
https://www.ncbi.nlm.nih.gov/pubmed/34603288
http://dx.doi.org/10.3389/fimmu.2021.714138

Ejemplares similares